This work is licensed under the Creative Commons Attribution 4.0 International License.
Fan Z, Chen L, Li J et al. Clinical features of COVID-19-related liver functional abnormality. Clin. Gastroenterol. Hepatol 2020;18(7):1561-6.FanZChenLLiJet alClinical features of COVID-19-related liver functional abnormality20201871561610.1016/j.cgh.2020.04.002Search in Google Scholar
https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020Search in Google Scholar
Qingxian C, Deliang H, Hong Y, et al. COVID-19: abnormal liver function tests. J Hepatol. 2020; Sep: 566-74. doi:/10.1016/j.jhep.2020.04.006QingxianCDeliangHHongYet alCOVID-19: abnormal liver function tests2020Sep56674doi:/10.1016/j.jhep.2020.04.006Open DOISearch in Google Scholar
Wang D, Hu B, Hu C,et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA.2020; 323 (11): 1061-1069. doi:10.1001/jama.2020.1585WangDHuBHuCet al2019novel coronavirus–infected pneumonia in Wuhan, China. JAMA.2020;323111061106910.1001/jama.2020.1585Open DOISearch in Google Scholar
Xiaolong Q, Chuan L, Jiang Z, et al. Multicenter analysis of clinical characteristics and outcomes in patients with COVID-19 who develop liver injury. J Hepatol. 2020; 73(2): 455–458. doi: 10.1016/j.jhep.2020.04.010XiaolongQChuanLJiangZet alMulticenter analysis of clinical characteristics and outcomes in patients with COVID-19 who develop liver injury202073245545810.1016/j.jhep.2020.04.010Open DOISearch in Google Scholar
Andrade RJ, Chalasani N, Bjornsson ES, et al. Drug-induced liver injury. Nature Reviews Disease Primers. 2019; 5(1): 1-22.AndradeRJChalasaniNBjornssonESet alDrug-induced liver injury20195112210.1038/s41572-019-0105-0Search in Google Scholar
Chaolin H, Yeming W, Xingwang L, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.The Lancet. 2020; 395.10223: 497-506. https://doi. org/10.1016/S0140-6736(20)30183-5ChaolinHYemingWXingwangLet al2019novel coronavirus in Wuhan, China.The Lancet. 2020; 3951022349750610.1016/S0140-6736(20)30183-5Open DOISearch in Google Scholar
Yang AP, Liu JP, Tao WQ, et al. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. International immunopharmacology. 2020;106504. https://doi.org/10.1016/j.intimp.2020.106504YangAPLiuJPTaoWQet alThe diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients202010650410.1016/j.intimp.2020.106504715292432304994Open DOISearch in Google Scholar
Henry BM, Santos de Oliveira MH, Benoit S, et al. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clinical Chemistry and Laboratory Medicine (CCLM). 2020; 58.7: 1021-1028. https://doi. org/10.1515/cclm-2020-0369HenryBMSantosde Oliveira MHBenoitSet al2019(COVID-19): a meta-analysis. Clinical Chemistry and Laboratory Medicine (CCLM). 2020; 5871021102810.1515/cclm-2020-036932286245Open DOISearch in Google Scholar
Yueying L, Xiao SY. Hepatic involvement in COVID‐19 patients: pathology, pathogenesis and clinical implications. Journal of medical virology. 2020; https://doi.org/10.1002/jmv.25973YueyingLXiaoSYHepatic involvement in COVID‐19 patients: pathology, pathogenesis and clinical implications202010.1002/jmv.2597332369204Open DOISearch in Google Scholar
Wiersinga WJ, Rhodes A, Cheng CA, et al. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. Jama. 2020; 324.8: 782-793. doi:10.1001/jama.2020.12839WiersingaWJRhodesAChengCAet al2019(COVID-19): a review. Jama. 2020; 324878279310.1001/jama.2020.1283932648899Open DOISearch in Google Scholar
Gupta A, Mandhavan M, Landry D, et al. Extrapulmonary manifestations of COVID-19. Nature medicine. 2020; 26.7: 1017-1032. https://doi.org/10.1038/s41591-020-0968-3.GuptaAMandhavanMLandryDet alExtrapulmonary manifestations of COVID-1920202671017103210.1038/s41591-020-0968-332651579Open DOISearch in Google Scholar
Bertolini A, Van de Peppel PI, Bodewes F et al. Abnormal liver function tests in COVID‐19 patients: relevance and potential pathogenesis. Hepatology. 2020; 72(5):1864-1872 https://doi.org/10.1002/hep.31480BertoliniAVande Peppel PIBodewesFet alAbnormal liver function tests in COVID‐19 patients: relevance and potential pathogenesis20207251864187210.1002/hep.31480740441432702162Open DOISearch in Google Scholar
Bloom PP, Trisha SP, Viveiros K. We know liver biochemistries are elevated in COVID-19, but should we be concerned?. Clinical Gastroenterology and Hepatology. 2020; 18.10: 23842385. https://doi.org/10.1016/j.cgh.2020.05.018BloomPPTrishaSPViveirosKWe know liver biochemistries are elevated in COVID-19, but should we be concerned?202018102384238510.1016/j.cgh.2020.05.018722974532425706Open DOISearch in Google Scholar
Alqahtani SA, Jörn MS. Liver injury in COVID-19: The current evidence. United European Gastroenterology Journal. 2020; 8.5: 509-519. https://doi.org/10.1177/2050640620924157AlqahtaniSAJörnMSLiver injury in COVID-19: The current evidence20208550951910.1177/2050640620924157726894932450787Open DOISearch in Google Scholar
Ridruejo E, Soza A. The liver in times of COVID-19: What hepatologists should know. Annals of Hepatology. 2020; 19(4):353-358RidruejoESozaAThe liver in times of COVID-19: What hepatologists should know202019435335810.1016/j.aohep.2020.05.001723323632425991Search in Google Scholar
Parohan M, Sajad Y, Asal S. Liver injury is associated with severe Coronavirus disease 2019 (COVID‐19) infection: a systematic review and meta‐analysis of retrospective studies. Hepatology Research.2020; 50(8):924-935. https://doi.org/10.1111/hepr.13510ParohanMSajadYAsalS2019202050892493510.1111/hepr.13510727309732386449Open DOISearch in Google Scholar
Boettler T, Newsome PN, Mondelli MU, et al. Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper. JHEP Reports. 2020; 2(3):100113. https://doi. org/10.1016/j.jhepr.2020.100113BoettlerTNewsomePNMondelliMUet alCare of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper20202310011310.1016/j.jhepr.2020.100113712847332289115Open DOISearch in Google Scholar
Jiang S , Wang R, Li L, et al. Liver Injury in Critically Ill and Non-critically Ill COVID-19 Patients: A Multicenter, Retrospective, Observational Study. Frontiers in medicine. 2020; 7:347. https://doi.org/10.3389/fmed.2020.00347JiangSWangRLiLet alLiver Injury in Critically Ill and Non-critically Ill COVID-19 Patients: A Multicenter, Retrospective, Observational Study2020734710.3389/fmed.2020.00347732479432656222Open DOISearch in Google Scholar
Bubenek S, Filipescu D, Grigoras I, et al. Ghid Societatea Romană de Anestezie și Terapie Intensivă – Terapia Intensivă a pacientului critic cu boală COVID-19 in secțiile ATI .2020. pp.30-38BubenekSFilipescuDGrigorasIet al2020pp3038Search in Google Scholar
Zheng Y, Song B. COVID-19 related liver injury: call for international consensus. Clinical Gastroenterology and Hepatology. 2020; 18(12): 2848–2851. https://doi. org/10.1016/j.cgh.2020.05.ZhengYSongBCOVID-19 related liver injury: call for international consensus202018122848285110.1016/j.cgh.2020.05Open DOISearch in Google Scholar